Alsanza

What Alsanza does

Alsanza Medizintechnik und Pharma GmbH is a privately held German medical device company headquartered in Pfullingen that develops and commercializes hyaluronic acid (HA)-based products across three therapeutic pillars: ophthalmology, orthopedics, and medical aesthetics. The company was founded in 2011 and operates with 51-100 employees, manufacturing in Germany under ISO 13485 quality systems with CE marking and MDR compliance.

The product portfolio is built on a shared high-purity, non-animal HA platform produced via bacterial bio-fermentation. In ophthalmology, Alsanza offers a full spectrum of intraocular lenses under the ALSEE (monofocal) and BOOST (toric) brands, the ALSAVISC ophthalmic viscosurgical device line, and the ALSAJET cartridge and injector system with proprietary ALSAGlide coating and MultiKnot plunger tip. In orthopedics, the company markets ALSAVIN, a non-cross-linked sodium hyaluronate for multi-dose intra-articular injection, and ALSASYN, a lightly cross-linked single-dose formulation with dual operational design for osteoarthritis treatment. In medical aesthetics, the Avillon Diamond collection provides CE-approved dermal fillers (Deep, Fine, Lips variants) built on TIC technology, complemented by the Avillon Hydrobooster and Hydrobooster Plus skin boosters leveraging Harmoni-HA technology.

Alsanza operates a B2B distribution model selling to healthcare professionals through a network of stockists and distributors globally, supplemented by direct customer service channels. Marketing is conducted via the corporate website, LinkedIn, Instagram, X.com, and Threads, with downloadable product brochures and a web-based Toric Calculator supporting surgeon engagement. Revenue is generated through one-time product sales across all three verticals; no pricing is publicly disclosed, and no funding rounds, investors, M&A activity, or revenue figures are available in the source data.

Name

Alsanza

Legal name

Alsanza Medizintechnik und Pharma GmbH

Website

https://alsanza.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

51–100 employees

Short description

Alsanza Medizintechnik und Pharma GmbH is a German medical device company that develops and sells hyaluronic acid-based products for ophthalmology (IOLs, OVDs, injectors), orthopedics (intra-articular injections), and medical aesthetics (dermal fillers, skin boosters), serving healthcare professionals through a global B2B distributor network.

Ownership category

akta.pro rank

Product category

Medical Devices

NAICS

Ophthalmic Goods Manufacturing (339115), Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)

SIC

Ophthalmic Goods (3851), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK)

akta.pro secondary industries

Ophthalmology Specialty Pharmaceuticals (HLAIACAK), Dermocosmetics & Medical-Grade Skincare (CRABAAAF)

Keywords

• Hyaluronic acid injectables
• Ophthalmic medical devices
• Intraocular lenses
• Dermal fillers aesthetics
• Osteoarthritis treatments

Headquarters

HQ city

Pfullingen

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Sales: Alsanza generates revenue through the sale of hyaluronic acid-based medical devices across three therapeutic areas: ophthalmology (IOLs, OVDs, cartridge systems), orthopedics (intra-articular injections), and medical aesthetics (dermal fillers, skin boosters). Products are sold through distributors and directly to healthcare professionals.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

Alsanza develops, manufactures, and sells hyaluronic acid (HA)-based medical devices across three therapeutic areas: ophthalmology (intraocular lenses, ophthalmic viscosurgical devices, and cartridge/injector systems), orthopedics (intra-articular injections such as ALSAVIN and ALSASYN for osteoarthritis), and medical aesthetics (Avillon Diamond dermal fillers and Hydrobooster skin boosters). All products are produced in Germany under ISO 13485 quality standards and sold B2B to healthcare professionals through distributors and direct sales channels.

Product overview

Alsanza is a medical device company offering hyaluronic acid-based products across three therapeutic areas: Medical Aesthetics, Ophthalmology, and Orthopedics. The product portfolio centers on HA technology with the Avillon Diamond collection (dermal fillers and skin boosters) for aesthetics, ALSAVIN/ALSASYN (intra-articular injections) for orthopedics, and a comprehensive ophthalmology suite including IOLs (monofocal, EDOF, trifocal, toric), ALSAVISC OVDs, and ALSAJET delivery systems. The company also provides a web-based Toric Calculator tool. All products share a foundation in high-purity, non-animal hyaluronic acid developed through bio-fermentation, with manufacturing under ISO 13485 quality standards in Germany.

Differentiator

Problem solved

Functional benefit

Brands

• ALSAVIN: High-molecular weight, non-animal hyaluronic acid intra-articular injection for multiple injections (3-5) with 1 week intervals, designed for osteoarthritis treatment and joint relief.
• ALSASYN
• ALSAVISC
• ALSAJET
• ALSEE
• BOOST
• Avillon Diamond
• Avillon Hydroboosters
• FOURIER

Products and services

• Avillon Diamond Collection (Dermal Fillers) CE-approved, highly purified, stabilized non-animal hyaluronic acid dermal filler collection with lidocaine, formulated with TIC (Tissue Integration and Compatibility) technology for facial rejuvenation. Includes Avillon Diamond Deep (cheeks and jawlines), Fine (fine lines), and Lips variants, sold to medical aesthetics practitioners.
• Avillon Hydroboosters (Skin Boosters) HA-based skin booster line featuring Hydrobooster and Hydrobooster Plus formulations using Harmoni-HA technology for deep hydration, skin conditioning, revitalization, and improved skin tone and firmness. Sold to medical aesthetics practitioners.
• ALSAVIN (Orthopedic Intra-Articular Injection) High-purity, non-animal, non-cross-linked sodium hyaluronate intra-articular injection administered as multiple injections (3-5 doses with 1-week intervals) for osteoarthritis treatment. Reduces joint stiffness, improves shock absorption, and supports natural mobility. Sold to orthopedic surgeons and rheumatologists.
• ALSASYN (Orthopedic Intra-Articular Injection) High-purity, lightly cross-linked sodium hyaluronate intra-articular injection in mono-dose formulation with Dual Operational Design combining cross-linked and linear HA for single-dose injection. Provides long-lasting relief and sustained mechanical support for osteoarthritis. Sold to orthopedic surgeons and rheumatologists.
• Monofocal Intraocular Lenses (ALSEE) Intraocular lenses providing clear vision at a single focal distance (typically far vision), manufactured from 100% glistening-free hydrophobic acrylic materials for long-term optical stability. Sold to ophthalmologists and eye surgeons for cataract surgery.
• EDOF Intraocular Lenses (Extended Depth of Focus) Intraocular lenses that extend the range of sharp focus through a continuous range of distances, offering functional vision at near, intermediate, and far distances with reduced visual disturbances. Sold to ophthalmologists for cataract and refractive surgery.
• Trifocal Intraocular Lenses Intraocular lenses dividing incoming light into multiple focal points to allow clear vision at near, intermediate, and far distances, with enhanced intermediate vision for computer use. Sold to ophthalmologists for cataract and refractive surgery.
• Toric Intraocular Lenses (BOOST) Intraocular lenses designed to correct corneal astigmatism using Fourier-based optic designs with precise alignment markers and rotational stability to maintain corrective power post-implantation. Sold to ophthalmologists for cataract and astigmatism correction.
• ALSAVISC (Ophthalmic Viscosurgical Devices) Ophthalmic Viscosurgical Device (OVD) portfolio formulated with high-purity, non-animal sodium hyaluronate, available in cohesive and dispersive formulations, providing chamber stability, tissue protection, and seamless surgical handling throughout cataract surgery. Sold to ophthalmologists.
• ALSAJET (Cartridge and Injector System) Cartridge and injector system with MultiKnot plunger tip and ALSAGlide hydrophilic coating for extra safety and stopless IOL delivery, available in 1.8, 2.2, and 2.4 ml sizes. Sold to ophthalmologists for IOL implantation procedures.

Quantifiable outcome

• High-purity, non-animal HA produced via bacterial bio-fermentation to pharmaceutical standards
• +1 more outcomes

Segments4 records

Ideal customer profiles3 records

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature9 records

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Galderma: World-leading dermatology/aesthetics company with the Restylane and Emervel HA dermal filler franchises. Direct competitive benchmark for Alsanza's Avillon Diamond aesthetics portfolio.
• Alcon: Global leader in ophthalmic surgery (IOLs, OVDs, cataract equipment) and vision care. Sets the competitive benchmark for Alsanza's IOL, ALSAVISC OVD, and ALSAJET injector portfolio.
• Carl Zeiss Meditec: German-listed ophthalmic medical device company with a deep IOL, surgical microscope, and ophthalmic equipment portfolio. Directly comparable to Alsanza's ophthalmology pillar and its Germany-based medical device positioning.
• Bausch + Lomb: Major ophthalmology medical device and pharmaceutical company with a leading IOL portfolio and surgical suite. Comparable to Alsanza's ophthalmology offering across cataract surgery products.

Direct peers

• Teoxane: Swiss HA-based medical aesthetics company selling the Teosyal range of dermal fillers globally. Closely comparable to Alsanza on HA platform technology, premium positioning, and European manufacturing heritage.
• Seikagaku Corporation: Japanese specialty company focused on HA-based products, with leading positions in intra-articular injections for osteoarthritis (Artz/Supartz). Directly comparable to Alsanza's ALSAVIN and ALSASYN orthopedic franchise.
• Anika Therapeutics: US-based specialty HA company producing orthopedic intra-articular injections (Monovisc, Orthovisc) and HA-based aesthetics. Closely comparable on HA platform technology across orthopedics and aesthetics.
• Bohus BioTech: Swedish HA-based medical device company with ophthalmology viscosurgical devices and HA aesthetic products. Closely comparable to Alsanza on European HA manufacturing and cross-therapeutic scope.
• Sinclair Pharma: European aesthetics-focused company selling HA fillers and biostimulators. Closely comparable to Alsanza's Avillon aesthetic portfolio and similar European mid-market positioning.
• NEAUVIA: European aesthetics brand selling a range of HA dermal fillers and skin boosters. Directly comparable to Alsanza's Avillon Diamond filler and Hydrobooster product lines.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/ena_supply
• LinkedInlinkedin.com/company/alsanza-gmbh
• Instagraminstagram.com/ena.supply

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Alsanza